Dow Down 1.29% Nasdaq Down 3.25%

More On NONOF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Novo Nordisk A/S (NONOF)

-Other OTC
49.29 Down 0.28(0.55%) Feb 5, 10:25AM EST
Prev Close:49.56
Open:49.29
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:0.521722
Next Earnings Date:N/A
Day's Range:49.29 - 49.29
52wk Range:41.90 - 59.90
Volume:41,201
Avg Vol (3m):46,326
Market Cap:125.85B
P/E (ttm):24.53
EPS (ttm):2.01
Div & Yield:0.73 (1.49%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.89
Ex-Dividend Date:20-Mar-15

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback